Bone metastases occur more frequently in patients with hormone receptor (HR)-positive/HER2-negative breast cancer than in those with other subtypes, although this subtype also displays lower rates of distant metastasis overall, according to an analysis of Surveillance, Epidemiology, and End Results (SEER) data conducted by investigators in China.
These findings, published in Oncotarget (2017;8[17]:27990-27996, PMID: 28427196), were drawn from SEER data from 2010 to 2013, specifically data on